These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 9618939)
61. Behavior of Mycoplasma hominis in a human diploid cell culture system. Sasaki T; Shintani M; Yamada K; Okumura H; Kihara K Microbiol Immunol; 1981; 25(6):537-43. PubMed ID: 7278706 [TBL] [Abstract][Full Text] [Related]
62. A multiplex polymerase chain reaction for discriminating Erysipelothrix rhusiopathiae from Erysipelothrix tonsillarum. Yamazaki Y J Vet Diagn Invest; 2006 Jul; 18(4):384-7. PubMed ID: 16921879 [TBL] [Abstract][Full Text] [Related]
63. Role of superoxide anion in host cell injury induced by mycoplasma pneumoniae infection. A study in normal and trisomy 21 cells. Almagor M; Kahane I; Yatziv S J Clin Invest; 1984 Mar; 73(3):842-7. PubMed ID: 6323529 [TBL] [Abstract][Full Text] [Related]
64. [Studies on the variability of the serological types of erysipelas bacteria (Erysipelothrix rhusiopathiae, syn. Erysipelothrix insidiosa)]. Wellmann G; Thal E Zentralbl Bakteriol Orig; 1967 Feb; 202(3):374-87. PubMed ID: 5599693 [No Abstract] [Full Text] [Related]
65. A suitable basal medium for evaluation of the fermentative capacity of Erysipelothrix rhusiopathiae. TIFFANY LW Am J Vet Res; 1955 Oct; 16(61 Part 1):636-8. PubMed ID: 13259053 [No Abstract] [Full Text] [Related]
66. Use of the protective antigen of Erysipelothrix rhusiopathiae in the enzyme-linked immunosorbent assay and latex agglutination. Sato H; Yamazaki Y; Tsuchiya K; Aoyama T; Akaba N; Suzuki T; Yokoyama A; Saito H; Maehara N Zentralbl Veterinarmed B; 1998 Sep; 45(7):407-20. PubMed ID: 9780828 [TBL] [Abstract][Full Text] [Related]
67. Isolation and partial purification of macrophage- and dendritic cell-activating components from Mycoplasma arthritidis: association with organism virulence and involvement with Toll-like receptor 2. Cole BC; Mu HH; Pennock ND; Hasebe A; Chan FV; Washburn LR; Peltier MR Infect Immun; 2005 Sep; 73(9):6039-47. PubMed ID: 16113324 [TBL] [Abstract][Full Text] [Related]
68. Identification of serovar 1a, 1b, 2, and 5 strains of Erysipelothrix rhusiopathiae by a conventional gel-based PCR. Shiraiwa K; Ogawa Y; Nishikawa S; Eguchi M; Shimoji Y Vet Microbiol; 2018 Nov; 225():101-104. PubMed ID: 30322520 [TBL] [Abstract][Full Text] [Related]
69. Septic polyarthritis caused by Erysipelothrix rhusiopathiae in a dog. Seelig U; Klopfleisch R; Weingart C; Walther B; Luebke-Becker A; Brunnberg L Vet Comp Orthop Traumatol; 2010; 23(1):71-3. PubMed ID: 19997677 [TBL] [Abstract][Full Text] [Related]
70. Protein and antigen variability among strains of Mycoplasma arthritidis. Stadtlander CT; Watson HL Zentralbl Bakteriol; 1992 Feb; 276(3):407-17. PubMed ID: 1576410 [TBL] [Abstract][Full Text] [Related]
71. Erysipelothrix septicemia in a little blue penguin (Eudyptula minor). Boerner L; Nevis KR; Hinckley LS; Weber ES; Frasca S J Vet Diagn Invest; 2004 Mar; 16(2):145-9. PubMed ID: 15053366 [TBL] [Abstract][Full Text] [Related]
72. TLR2 and TLR4 differentially regulate B7-1 resulting in distinct cytokine responses to the mycoplasma superantigen MAM as well as to disease induced by Mycoplasma arthritidis. Mu HH; Humphreys J; Chan FV; Cole BC Cell Microbiol; 2006 Mar; 8(3):414-26. PubMed ID: 16469054 [TBL] [Abstract][Full Text] [Related]
73. [Selective liquid culture media for Erysipelothrix rhusiopathiae]. BRILL J; SZYNKIEWICZ Z Med Dosw Mikrobiol; 1952; 4(3):324-5. PubMed ID: 13001987 [No Abstract] [Full Text] [Related]
74. Erysipelothrix rhusiopathiae bloodstream infection - A 22-year experience at Mayo Clinic, Minnesota. Tan EM; Marcelin JR; Adeel N; Lewis RJ; Enzler MJ; Tosh PK Zoonoses Public Health; 2017 Nov; 64(7):e65-e72. PubMed ID: 28206705 [TBL] [Abstract][Full Text] [Related]
75. [Liquid enriched medium with egg yolk for cultivation of Erysipelothrix rhusiopathiae]. SZYNKIEWICZ Z Acta Microbiol Pol (1952); 1956; 5(1-2):81-4. PubMed ID: 13394230 [No Abstract] [Full Text] [Related]
76. Human fibroblasts release low amounts of reactive oxygen species in response to the potent phagocyte stimulants, serum-treated zymosan, N-formyl-methionyl-leucyl-phenylalanine, leukotriene B4 or 12-O-tetradecanoylphorbol 13-acetate. Meier B; Radeke HH; Selle S; Habermehl GG; Resch K; Sies H Biol Chem Hoppe Seyler; 1990 Oct; 371(10):1021-5. PubMed ID: 1963784 [TBL] [Abstract][Full Text] [Related]